Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Wallenstam starts commercial segment in CBD Stockholm and buys the scraper next to Sergels Torg square

Wallenstam has today signed an agreement on the acquisition of the scraper next to Sergels Torg square, number 5 of the Hötorget scrapers, and is thereby starting a new venture in the commercial segment in Stockholm’s CBD. Our vision is to refine and modernize this iconic building both internally and externally, and create attractive premises with amazing views over central Stockholm.“We have been waiting for the right property and the right opportunity to enter the commercial market in Stockholm. The acquisition of the scraper next to Sergels Torg will be a fantastic starting point for our

Nomination committee for OrganoClick for the 2025 Annual General Meeting

In accordance with the decision taken at the 2024 annual general meeting, OrganoClick AB's nomination committee consists of representatives of the three largest owners as of the 30 September 2024. This year's nomination committee includes Peter Lindell representing Cidro Förvaltning AB, Johan Wall representing Beijer Ventures AB and the Beijer foundations and Mårten Hellberg representing M. Hellberg AB and himself. As chairman of the Nomination Committee, Peter Lindell was appointed as the largest individual shareholder in OrganoClick AB.The members of the nomination committee together

Alzinova’s new CEO to BioStock: “The next six months will be really exciting”

Tord Labuda has entered the role as CEO of Alzinova, bringing extensive experience from leading positions in the pharmaceutical industry. The company is in an exciting development phase, as the clinical phase Ib study with the Alzheimer’s vaccine ALZ-101 is expected to be completed in early 2025. In preparation for phase II, Alzinova is actively exploring opportunities for licensing agreements with a larger pharma company.Read the full interview with Tord Labuda at biostock.se: https://www.biostock.se/en/2024/10/alzinovas-new-ceo-the-next-six-months-will-be-really-exciting/ This is a

Young Finnish start-up Exolyt, specialising in short-form social media intelligence, gets nominated among the top 10 for EY Entrepreneur of the Year Suomi

Exolyt challenges big players in a global market by specialising in a new vertical and highly competitive space of the rapidly growing TikTok social media market.HELSINKI, Finland (10 October 2024) – Exolyt , a B2B SaaS platform offering TikTok analytics and social intelligence insights, has been nominated as one of the top 10 companies in EY Entrepreneur of the Year Finland . This time, 53 companies participated in this prestigious competition, which rewards family businesses, tech companies, and startups.   With over a billion

Suspension of Trading

SUSPENSION OF TRADING Vancouver, British Columbia, 10 October 2024— Mydecine Innovations Group Inc. (the “Company”) (CSE: MYCO) (FSE: 0NF0) (OTC: MYCOF) (AQSE: MYIG) announces that its shares have been suspended from trading on the Aquis Growth Market for failure to pay exchange fees pursuant to Rule 3.10 of the Aquis Stock Exchange Rulebook (Access) with effect from today, 10/10/2024.   The Directors of Mydecine take responsibility for this announcement. This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as

Electrolux Group chooses sustainability-linked loan from Svensk Exportkredit

AB Electrolux and Svensk Exportkredit (SEK) have entered into a financing agreement for USD 100 million. The loan is linked to Electrolux Group’s sustainability goals aimed at reducing the company's climate impact.Press release October 10, 2024 Electrolux Group chooses sustainability-linked loan from Svensk Exportkredit AB Electrolux and Svensk Exportkredit (SEK) have entered into a financing agreement for USD 100 million. The loan is linked to Electrolux Group’s sustainability goals aimed at reducing the company's climate impact. The USD 100 million financing from Svensk

Prolight’s COO to BioStock: “The pilot line sets the stage for scalability”

Prolight Diagnostics recently completed a business review of the pilot manufacturing line at its partner, FlexMedical Solutions. The production line will supply cartridges for the upcoming clinical performance study of the Psyros POC platform and facilitate a seamless transition to full-scale commercial production. Prolight’s COO, Karl Bullen, shared insights into the progress and next steps.Read the full article at biostock.se : https://www.biostock.se/en/2024/10/prolights-coo-the-pilot-line-sets-the-stage-for-scalability/ This is a press release from

Publication of Prospectus

The following Prospectus has been approved by the Financial Conduct Authority on 9 October 2024 and is available for viewing:   The Prospectus dated 9 October 2024 (the "Prospectus") for the update of the €10,000,000,000 Global Secured Medium Term Note Global Secured Medium Term Note Programme, with Anglian Water Services Financing PLC as the issuer and (i) Anglian Water Services Limited, (ii) Anglian Water Services Holdings Limited and (iii) Anglian Water Services UK Parent Co Limited as the guarantors.   To view the Prospectus, please follow the link below   AWSF

Oncoinvent Announces First Patient Dosed in its Phase 2 Clinical Trial of Radspherin® in Ovarian Cancer Patients

Oncoinvent, a clinical stage, radiopharmaceutical company developing innovative treatments for solid cancers, today announced that the first patient has been dosed in its Phase 2 study of Radspherin® in patients with peritoneal carcinomatosis from ovarian cancer. Radspherin® is a novel alpha-radiation therapy candidate designed for targeted, local treatment of cancers that have spread to body cavities. The Phase 2 trial is a randomized controlled study designed to assess progression-free survival (PFS) in primary advanced ovarian cancer patients treated with Radspherin® following complete

BerGenBio ASA: Minutes from Extraordinary General Meeting

Bergen, Norway,10 October 2024 – An Extraordinary general meeting of BerGenBio ASA was virtually held today 10 October 2024 at 10.00 CEST.   All proposals were resolved as presented in the notice convening the extraordinary general meeting distributed on 19 September 2024 as further set out in the minutes from the extraordinary general meeting attached hereto and available at https://www.bergenbio.com/investors/general-meetings/.   For further information, please contact:   Martin Olin CEO, BerGenBio ASA ir@bergenbio.com   Rune Skeie CFO, BerGenBio ASA rune.

Invitation to webcasted telephone conference – Q3 2024

Billerud’s interim report for the third quarter 2024 will be published on Thursday 24 October at around 7.00 CEST.Billerud’s President and CEO Ivar Vatne and CFO Andrei Krés will present the interim report in a webcasted telephone conference on the same day at 8:30 CEST. The presentation will be held in English and will be followed by a Q&A session.The presentation can be followed on https://edge.media-server.com/mmc/p/uqomewt9To participate via telephone, and thereby be able to ask questions, please register here: https://register.vevent.com/register/BI302dc89e51e541ccbcc01957490f37d3

Conference call interim report

Invitation to attend Vitrolife AB (publ) conference call regarding presentation of the interim report Q3, 2024. The presentation will be held in English.Time: Thursday 24 October, 2024 at 10.00 a.m. CET. To attend the conference call, please use this link to register. After registration, you will be provided with telephone numbers, conference PIN, and personal PIN to access the conference. Your personal data will be processed in accordance with our privacy policy available at: Privacy policy | Vitrolife Group 

Mainstream Renewable Power and Ocean Winds project secures grid connection for 1.1 GW floating offshore wind farm in South Korea

Mainstream Renewable Power ("Mainstream"), the pureplay global wind and solar company majority-owned by Aker Horizons ASA, announced that the joint venture KF Wind, a floating offshore wind project being developed off the coast of Ulsan by Ocean Winds and Mainstream, has secured a Transmission Service Agreement (TSA) with Korea Electric Power Corporation (KEPCO) for a total of 1,125 MW of clean power to be injected into Korea’s national grid.The agreement covers the first phase of the project, East Blue Power (375 MW) and the second phase, KF Wind (750 MW) with the interconnection point for

Form 8.3 - Anglogold Ashanti Plc

FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   +--------------------------------------------------------+---------------------+|(a) Full name of discloser: |Ninety One UK Ltd |+--------------------------------------------------------+---------------------+|(b) Owner or controller of interests and short positions|  ||disclosed, if different from 1(a):

Multimillion-pound boost for regional mental health research

Teesside University has secured a prestigious National Institute for Health and Care Research (NIHR) Mental Health Research Leader Award of nearly £2.5m to build infrastructure, capacity and capability in applied mental health research.The award funded by the NIHR will support academics from the University’s School of Health & Life Sciences and School of Social Sciences, Humanities & Law as they establish, explore and address key mental health research challenges in the region. The project, led by Professor Emma Giles, has already identified key priorities for mental health research in

GenesisCare UK selects RayStation

RaySearch Laboratories AB (publ) is pleased to announce that GenesisCare UK has placed an order for the RayStation®* treatment planning system.GenesisCare is the UK's leading independent cancer care provider, operating 14 specialist outpatient cancer centers. This order signifies the plan to fully replace its current Pinnacle radiotherapy treatment planning system with RayStation.   The advanced technology licenses acquired will support GenesisCare's dedication to delivering high precision advanced treatment techniques, enhancing their established adaptive radiotherapy capabilities.

AddSecure among top 5 nominees for “Newcomer of the Year” at the Great Career Day 2024

AddSecure was one of the five finalists for the “IT Newcomer of the Year” award at the Great Career Day 2024, which took place yesterday in Stockholm, Sweden.AddSecure , a leading European provider of secure IoT connectivity and end-to-end solutions, was among the top 5 nominees for the “Newcomer of the Year” award in the IT category in IT. The award was presented by Career Companies (Karriärföretagen) at a gala in Stockholm yesterday and the winner was Visma Spcs.   “We are very happy to have been nominated and proud that the work we do together every

Read original

Invitation to presentation of Q3 2024 financial results

Viaplay Group will publish its Q3 2024 financial results at 07:30 CET on Tuesday 22 October. A conference call, including a question-and-answer session, will be held at 09:00 CET on Tuesday 22 October with presentations by Jørgen Madsen Lindemann (President and CEO) and Johan Johansson (CFO and Co-CEO Sweden). Online To view slides and listen to the conference call online, please use the following link, where questions can also be posted: https://edge.media server.com/mmc/p/4bkvq9dt PhonePlease register here if you would prefer to dial in and ask questions over the phone: https:

Advania acquires UK based IT solution specialist CCS Media to further accelerate growth

Advania, a portfolio company of Goldman Sachs Alternatives and one of the largest providers of IT services in Northern Europe, has announced the acquisition of CCS Media, one of the largest independent IT solutions providers in the United Kingdom. This acquisition aligns with Advania's strategic focus on expanding both its footprint and its capability within the UK market. The combination will enable a highly complementary solutions and services offering, providing top tier depth and breadth of expertise across an end-to-end customer-centric offering commensurate with the group’s overall

Invitation – SEB’s results for the third quarter 2024

On Thursday 24 October, at approximately 07:00 CET, SEB’s results for the third quarter 2024 will be announced. In addition, presentations and the Fact Book will be available on sebgroup.com/ir.  You are invited to participate in the following event:  Telephone conference Time: 09:00 CET Johan Torgeby, SEB’s President and CEO, and Christoffer Malmer, CFO, will present the results, followed by a Q&A session with Johan Torgeby, Christoffer Malmer and Pawel Wyszynski, Head of Investor Relations. The presentation and Q&A will be conducted in English.  To participate in the

Invitation to presentation of Betsson AB’s results for the third quarter 2024

On Thursday, 24 October 2024, at 07:30 CEST, Betsson will publish its interim report for the third quarter of 2024. At 10:00 CEST on the same day, Betsson invites analysts, investors, and media to a presentation of the results.The results will be presented by CEO Pontus Lindwall and CFO Martin Öhman. The presentation will be held in English, followed by a Q&A session. Participants are welcome to join via webcast or phone. Link with information on how to participate in the webcast and telephone conference: https://financialhearings.com/event/49078   For further information,

Invitation to presentation of Pandox’s interim report January–September 2024

Pandox AB (publ) publishes the interim report for the period January–September 2024 on 24 October 2024, at 07:00 CEST, followed by a webcasted telephone conference at 08:30 CEST.   Afterwards, a proprietary presentation on the international hotel market, separate from Pandox’s earnings presentation, will be held by Thomas Emanuel, Senior Director at STR International. Teleconference If you wish to participate via teleconference, please register via the following link: https://conference.financialhearings.com/teleconference/?id=50048984. After registration you will be provided

Nomination Committee for the AGM 2025

In accordance with the decision at Formpipe Software's Annual General Meeting on April 25, 2024, the Chairman, Annikki Schaeferdiek, has called together the Nomination Committee. After consultation with the company's, as of September 30, 2024, largest shareholder in terms of votes, the Nomination Committee consists of the following members: · Emil Hjalmarsson become Chairman of the Nomination Committee representing Aktiebolag Grenspecialisten · Joshua Braden, representing Mission Trail · Petter Mattsson, representing Alcur · Mathias Nimlin, representing Martin Bjäringer

There are no items matching the current filter
There are no more items matching the current filter
Back to top